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Introduction – Environmental Sustainability 
& Process Intensification (PI) 
 
Introduction – Is PI Environmentally 
Sustainable? 
13.02.2014 ie-net Workshop Process Intensification, from Batch to Continuous  3 
 
PI: DO MORE WITH LESS 
 
LESS/LEAN: 
How to measure? 
 
Take into account  
complete lifecycle of 
a product/service! 
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• How to quantify all different kinds of resource? Energetic, physical 
resources? 
Resources Exergyin 
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• Combination of Process Analysis (EA) and Life Cycle Analysis (ELCA) 
– Identification, localization and reduction of environmental burdens 
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Introduction – System boundaries 
OVERALL INDUSTRIAL ENVIRONMENTAL PROCESSES
(Industrial level, cradle-to-gate γ)
PLANT SPECIFIC SUPPORTING CORE PROCESSES
(Plant level, gate-to-gate β)
ENVIRONMENT (at cradle)
β Boundary System
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CORE PROCESSES DRUG MANUFACTURING 
(Process Level α)
α Boundary System
Case 1: Primary Pharmaceutical 
Manufacturing (API) 
Case 1: Three Galantamine generations 
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• Comparative environmental sustainability assessment of 3 
generations of Galantamine 
• Shift from conventional batch reactors to continuous 
flow microreactors in synthesis step 6 
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Van der Vorst et al., 2013. Green Chemistry. 
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Third generation 
Microreactor 
technology  
BATCH 
CONTINUOUS 
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• +- 41% reduction in integral resource consumption of 
Galantamine synthesis steps (MJex/mole intermediate) 
41% 
2nd 3rd 
Van der Vorst et al., 2013. Green Chemistry. 
Case 1: Three Galantamine generations 
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Case 2: Secondary 
Pharmaceutical Manufacturing 
(Dosage Forms) 
Case 2: Tramacet Drug Product Production (tablet) 
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• Exergetic sustainability assessment of batch versus 
continuous wet granulation based pharmaceutical tablet 
manufacturing: a cohesive analysis at three different levels 
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Case 2: Tramacet Drug Product Production (tablet) 
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Process Plant Life Cycle 
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Case 2: Tramacet - What about the supply chain? 
De Soete et al., 2013.  
Green Chemistry. 
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Case 2: Tramacet – Final Results 
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• Huge step forward towards Greener Formulation Processes 
• Further reduce impact through: 
– In-line blending and in-line coating 
– Re-using treated wastewater for cooling or cleaning purposes 
– Recycling exhaust air for heating purposes 
• Sensitive parameters: 
– API dosage 
– # tablets per folding box (packaging) 
 
De Soete et al., 2013. Green Chemistry. 
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Results overview and future outlook 
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• Substantial knowledge on environmental impact of API synthesis 
processes 
• Need to move downstream in supply chain: what about 
distribution networks? Logistics? Use phase? Waste management? 
• Need for generic forecasting models in R&D environments 
• Take into account other impacts as well (e.g. Human Health)  
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